Elicio Therapeutics, Inc. ( ELTX) - Stock Earnings
ELTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -7.7 million USD | — USD |
| 2026Q1 | -11.8 million USD | — USD |
| 2026Q2 | -8.2 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
ELTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -35.2 million USD | — USD |
| 2024 | -51.9 million USD | — USD |
| 2025 | -39.6 million USD | — USD |
| 2026 Est. | — | — |
ELTX
Price: $3.04
52 week price:
Earnings Per Share: -2.21 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 81.7 million